C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/13 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) C07K 1/16 (2006.01) C07K 16/28 (2006.01) C07K 16/42 (2006.01) C12N 5/00 (2006.01) G01N 33/543 (2006.01) G01N 33/577 (2006.01) A61K 38/00 (2006.01) A61K 43/00 (1990.01)
Patent
CA 2132540
Hybridomas (termed "UIC2 hybridoma", ATCC Accession No. HB11207 and "UIC2/A hybridoma", ATCC Accession No. HB11287) producing monoclonal antibody (termed "UIC2 mAb") directed against an extracelluar domain of a cell surface P-glycoprotein antigen associated with multidrug resistance in primate cells was produced by fusing a human myeloma cell with a spleen cell derived from a Balb/c mouse immunized with syngeneic 3T3 fibroblasts previously transfected with the isolated human mdrl cDNA. UIC2 mAb, thus produced, as well as fragments and recombinant derivative thereof, may be used to detect and isolate multidrug resistant primate cells and human mdrl gene products, and to reverse multidrug resistance in primate cells, including cells of multidrug resistant human tumours.
Mechetner Eugene
Roninson Igor B.
Mbm Intellectual Property Law Llp
The Board Of Trustees Of The University Of Illinois
LandOfFree
A monoclonal antibody to a human mdr1 multidrug resistance... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A monoclonal antibody to a human mdr1 multidrug resistance..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A monoclonal antibody to a human mdr1 multidrug resistance... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1965094